Cite
How do patients and other members of the public engage with the orphan drug development? A narrative qualitative synthesis.
MLA
Frost, Julia, et al. “How Do Patients and Other Members of the Public Engage with the Orphan Drug Development? A Narrative Qualitative Synthesis.” Orphanet Journal of Rare Diseases, vol. 18, no. 1, Apr. 2023, pp. 1–24. EBSCOhost, https://doi.org/10.1186/s13023-023-02682-w.
APA
Frost, J., Hall, A., Taylor, E., Lines, S., Mandizha, J., & Pope, C. (2023). How do patients and other members of the public engage with the orphan drug development? A narrative qualitative synthesis. Orphanet Journal of Rare Diseases, 18(1), 1–24. https://doi.org/10.1186/s13023-023-02682-w
Chicago
Frost, Julia, Abi Hall, Emily Taylor, Sarah Lines, Jessica Mandizha, and Catherine Pope. 2023. “How Do Patients and Other Members of the Public Engage with the Orphan Drug Development? A Narrative Qualitative Synthesis.” Orphanet Journal of Rare Diseases 18 (1): 1–24. doi:10.1186/s13023-023-02682-w.